Company:  BIOPHARMX CORP (BPMX)
Form Type:  10-Q
Filing Date:  6/14/2017 
CIK:  0001504167 
Address:  1505 ADAMS DRIVE, SUITE D 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650-889-5020 
Fiscal Year:  01/31 
Last Trade
Last Trade: 
$0.28  
Change: 
-0.0184 (-6.13%)  
Trade Time: 
10:46 AM EST  
Market Cap: 
$22.47M
Trade BPMX now with 

© 2017  
Description of Business
We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.
Register and access this filing in:     
  FORM 10-Q
    PART I
      ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
          BALANCE SHEET
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 3. DEFAULTS UPON SENIOR SECURITIES
      ITEM 4. MINE SAFETY DISCLOSURES
      ITEM 5. OTHER INFORMATION
      ITEM 6. EXHIBITS
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1